Absolute monocyte count is a prognostic indicator in a patient with diffuse large B-cell lymphoma after autologous peripheral blood stem cell transplant

Leukemia and Lymphoma

Volumn 56, Issue 2, 2015, Pages 515-517

  Mo, Hongnan ^a   Shi, Yuankai ^a   Han, Xiaohong ^a   Zhou, Shengyu ^a   He, Xiaohui ^a   Liu, Peng ^a   Yang, Jianliang ^a   Zhang, Changgong ^a   Yang, Shen ^a   Qin, Yan ^a   Gui, Lin ^a   Shi, Youwu ^a   Yao, Jiarui ^a   Zhao, Liya ^a   Zhang, Shuxiang ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT;

ABSOLUTE MONOCYTE COUNT; ACUTE GRANULOCYTIC LEUKEMIA; AREA UNDER THE CURVE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CELL COUNT; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; LARGE CELL LYMPHOMA; LETTER; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; AUTOTRANSPLANTATION; DISEASE FREE SURVIVAL; DOSE RESPONSE; FOLLOW UP; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; LYMPHOMA, LARGE B-CELL, DIFFUSE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATHOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROCEDURES; PROGNOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; LYMPHOMA, LARGE B-CELL, DIFFUSE; MONOCYTES; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84923921629     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.920504     Document Type: Letter

References (13)

1. N ational Comprehensive Cancer Network. 2014 NCCN Clinical Practical Guidelines in Oncology. Non-Hodgkin's Lymphomas. Available from: www.nccn.org
2. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994
3. V aidya R, Witzig T E. P rognostic factors for diff use large B cell lymphoma in the R(X)CHOP era. Ann Oncol 2014 Mar 13. [Epub ahead of print]
4. Tadmor T, Bari A, Sacchi S, et al. Monocyte count at diagnosis is a prognostic parameter in diff use large B-cell lymphoma: a large multicenter study involving 1191 patients, in the pre and post rituximab era. Haematologica 2014; 99: 125-130
5. Li YL, Pan YY, Jiao Y, et al. Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diff use large B cell lymphoma after standard fi rst-line regimens. Ann Hematol 2014; 93: 617-626
6. Koh YW, Kang HJ, Park C, et al. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages. Oncologist 2012; 17: 871-880
7. Lin Y, Gustafson MP, Bulur PA, et al. Immunosuppressive CD14 HLA-DR(low)/-monocytes in B-cell non-Hodgkin lymphoma. Blood 2011; 117: 872-881
8. Wada N, Zaki MA, Hori Y, et al. Tumour-associated macrophages in diff use large B-cell lymphoma: a study of the Osaka Lymphoma Study Group. Histopathology 2012; 60: 313-319
9. H erishanu Y, Kay S, Sarid N, et al. A bsolute monocyte count trichotomizes chronic lymphocytic leukemia into high risk patients with immune dysregulation, disease progression and poor survival. Leuk Res 2013; 37: 1222-1228
10. Th oma MD, Huneke TJ, DeCook LJ, et al. Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2012; 18: 600-607
11. Watanabe R, Tomita N, Kishimoto K, et al. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. Leuk Res 2013; 37: 1208-1212
12. Porrata LF, Ristow K, Markovic SN. Absolute monocyte count at diagnosis and survival in mantle cell lymphoma. Br J Haematol 2013; 163: 545-547
13. Wilcox RA, Ristow K, Habermann TM, et al. The absolute monocyte and lymphocyte prognostic score predicts survival and identifi es high-risk patients in diff use large-B-cell lymphoma. Leukemia 2011; 25: 1502-1509.